Cancer News
OncoLink Cancer News - HealthDay


Important developments in Hematology & Oncology for March 2011

Friday, April 1, 2011 (Last Updated: 04/04/2011)

Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for March 2011. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Unmet Health Care Needs in Survivors of Childhood Cancer

WEDNESDAY, March 23 (HealthDay News) -- Double informant data indicate that a considerable percentage of adult survivors of childhood central nervous system tumors have long-term unmet health care needs (HCNs), according to a study published online March 8 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Two-Thirds of U.S. Residents Get Sufficient Vitamin D

WEDNESDAY, March 30 (HealthDay News) -- About two-thirds of the U.S. population takes in sufficient amounts of vitamin D, but 8 percent may be at risk for vitamin D deficiency, according to a March data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.

More Information

Small Number of Second Cancers Linked to Radiotherapy

WEDNESDAY, March 30 (HealthDay News) -- Only a small proportion of second cancers are attributable to radiotherapy for primary tumors in adults, according to a study published online March 30 in The Lancet Oncology.

Abstract
Full Text (subscription or payment may be required)

Online Health Records Less Used by Minorities, Poor

WEDNESDAY, March 30 (HealthDay News) -- Online personal health records (PHRs) are less frequently used by racial or ethnic minorities and patients with low annual income, according to a study published in the March 28 issue of the Archives of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Basophil Infiltration Into Skin Lesions Common

WEDNESDAY, March 30 (HealthDay News) -- Immunohistochemical analysis reveals that basophils infiltrate into skin lesions in numerous skin diseases, according to a study published online March 4 in Allergy.

Abstract
Full Text (subscription or payment may be required)

PSA Screening Predicted by Age, Life Expectancy

TUESDAY, March 29 (HealthDay News) -- Age and life expectancy are strong predictors of prostate-specific antigen (PSA) screening, which appears to be administered excessively to older men with limited life expectancy, according to research published online March 28 in the Journal of Clinical Oncology.

Abstract
Full Text

Ethnicity Tied to Worry About Breast Cancer Recurrence

TUESDAY, March 29 (HealthDay News) -- Race and ethnicity have a significant impact on the amount women with breast cancer worry about recurrence, with less acculturated Latina women being especially susceptible to high levels of worry, according to a study published online March 28 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Radiation Risk From Airport Full-Body Scanners Limited

TUESDAY, March 29 (HealthDay News) -- Full-body scanners being deployed by the Transportation Security Administration in airports throughout the United States do not appear to increase risks related to radiation exposure, according to a special article published online March 28 in the Archives of Internal Medicine.

Abstract
Full Text

Decline Seen in Global Youth Mortality Over Last 50 Years

TUESDAY, March 29 (HealthDay News) -- Overall mortality declined substantially between 1955 and 2004 in children aged 14 years or younger and in females aged 15 to 24, but a smaller decline was evident for males aged 15 to 24 years, according to a study published online March 29 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Chemotherapeutic Agent Voluntarily Recalled

MONDAY, March 28 (HealthDay News) -- Five lots of irinotecan hydrochloride injection are being voluntarily recalled by APP Pharmaceuticals Inc. after foreign material and non-sterility were discovered in one lot of irinotecan injection, the U.S. Food and Drug Administration has announced.

More Information

Guidelines Provided for Deep Vein Thrombosis Management

MONDAY, March 28 (HealthDay News) -- Blood thinners should not be the only therapy considered for patients with deep vein thrombosis (DVT), according to a scientific statement published online March 21 in Circulation.

Full Text

Drug Approved for Late-Stage Melanoma

FRIDAY, March 25 (HealthDay News) -- The drug Yervoy (ipilimumab) has been approved by the U.S. Food and Drug Administration to treat late-stage melanoma, the deadliest form of skin cancer.

melanoma

Hormone Therapy Improves Prostate Cancer Survival

FRIDAY, March 25 (HealthDay News) -- In men with locally advanced prostate cancer, six months of hormone therapy combined with radiation significantly reduces prostate-cancer-specific and all-cause mortality compared with radiotherapy alone, according to a study published online March 25 in The Lancet Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Libido Unaffected by Endocrine Therapy in Breast Cancer

FRIDAY, March 25 (HealthDay News) -- Sexual desire in patients with breast cancer is not affected by adjuvant endocrine therapy, but is significantly reduced in those women with chemotherapy- or gonadotropin releasing hormone (GnRH) agonist-induced menopause, according to a study published online March 2 in The Journal of Sexual Medicine.

Abstract
Full Text (subscription or payment may be required)

Imatinib Improves Survival in Chronic Myeloid Leukemia

FRIDAY, March 25 (HealthDay News) -- Patients with chronic myeloid leukemia (CML) in complete cytogenetic remission (CCyR) for two years after starting imatinib have similar survival to that of the general population, according to a study published online March 21 in the Journal of the National Cancer Institute.

Abstract
Full Text (subscription or payment may be required)
Editorial

Novel Immune Therapy Attacks Pancreatic Tumor Stroma

FRIDAY, March 25 (HealthDay News) -- A novel immune therapy using CD40 agonist antibodies to attack the stroma surrounding pancreatic tumors appears to show efficacy in mice and humans, according to a study published online March 25 in Science.

Abstract
Full Text (subscription or payment may be required)

Menthol Cigarette Smokers Have Lower Cancer Rates

THURSDAY, March 24 (HealthDay News) -- Menthol and non-menthol cigarette smokers have similar quitting rates, but menthol smokers have lower lung cancer incidence and mortality, according to a study published online March 23 in the Journal of the National Cancer Institute.

Abstract
Full Text (subscription or payment may be required)

Maternal Anemia Associated With Childhood Wheezing

THURSDAY, March 24 (HealthDay News) -- Maternal anemia during pregnancy is linked with wheezing and asthma in early childhood, according to a study published in the February issue of the Annals of Allergy, Asthma & Immunology.

Abstract
Full Text (subscription or payment may be required)

Thromboembolism May Recur With Residual Vein Obstruction

THURSDAY, March 24 (HealthDay News) -- In patients with provoked or unprovoked deep vein thrombosis (DVT), residual vein obstruction (RVO) is associated with a slight increase in the risk of recurrent venous thromboembolism (VTE) but does not seem to predict recurrent VTE in patients with unprovoked DVT following discontinuation of anticoagulation therapy, according to a meta-analysis published online March 7 in the Journal of Thrombosis and Haemostasis.

Abstract
Full Text (subscription or payment may be required)

Window Period Infection Risk Low in High-Risk HIV Donors

THURSDAY, March 24 (HealthDay News) -- Among HIV high-risk donors (HRDs), the predicted risk of window period (WP) infection is low and varies significantly according to donor behavior, according to a meta-analysis published online March 2 in the American Journal of Transplantation.

Abstract
Full Text (subscription or payment may be required)

High Alcohol Intake Not Tied to Esophageal Adenocarcinoma

THURSDAY, March 24 (HealthDay News) -- Higher alcohol consumption is associated with an increased risk of esophageal squamous cell carcinoma (ESCC) but not with esophageal adenocarcinoma (EA) or adjacent tumors of the esophagogastric junction (EGJA), according to research published online March 14 in Gut.

Abstract
Full Text (subscription or payment may be required)

Reduced Hours for Trainees Has Had Little Effect in U.S.

THURSDAY, March 24 (HealthDay News) -- Reducing work hours for doctors in training to less than 80 per week has had little impact on patient outcomes or postgraduate training in the United States, according to a literature review published online March 22 in BMJ.

Abstract
Full Text
Editorial

Shorter Closure Time for in Vitro Adult Platelet Transfusion

WEDNESDAY, March 23 (HealthDay News) -- Transfusion of adult platelets into neonatal blood results in shorter platelet function analyzer closure time compared with neonatal platelets, according to a study published online Feb. 14 in the Journal of Thrombosis and Haemostasis.

Abstract
Full Text (subscription or payment may be required)

Dalteparin Not Superior to Unfractionated Heparin

TUESDAY, March 22 (HealthDay News) -- Dalteparin, a low-molecular-weight heparin, does not appear any more effective in lowering the incidence of proximal deep-vein thrombosis than unfractionated heparin, according to research published online March 22 in The New England Journal of Medicine.

Abstract
Full Text

Long-Term Tamoxifen Lowers Breast CA Recurrence Risk

TUESDAY, March 22 (HealthDay News) -- Women with breast cancer who take tamoxifen for five years appear to have a lower risk of recurrence or contralateral breast cancer 15 years after starting treatment as compared to women who take the drug for two years, and they may also have a lower risk of cardiovascular disease and death from a cardiovascular event, according to a study published online March 21 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial

Increased Melanoma Incidence Tied to Socioeconomic Status

TUESDAY, March 22 (HealthDay News) -- High socioeconomic status (SES) and exposure to ultraviolet-radiation (UV-R) are associated with increased malignant melanoma incidence among adolescent girls and young women, according to a study published online March 21 in the Archives of Dermatology.

Abstract
Full Text (subscription or payment may be required)

Multiple Sclerosis Slows After Stem Cell Transplant

TUESDAY, March 22 (HealthDay News) -- Patients with multiple sclerosis (MS) with active lesions who undergo hematopoietic stem cell transplantation (HSCT) have improved progression-free survival compared to patients without active lesions, according to a study published in the March 22 issue of Neurology.

Abstract
Full Text (subscription or payment may be required)

Seven-Day On-Off Capecitabine Cycle Treats Breast Cancer

TUESDAY, March 22 (HealthDay News) -- Treatment of metastatic breast cancer (MBC) with capecitabine administered for seven days followed by seven days of rest in combination with bevacizumab has modest efficacy and minimal toxicity, as predicted previously by mathematical modeling, according to a study published online March 8 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Taiwanese With Diabetes at Higher Risk of Prostate Cancer

MONDAY, March 21 (HealthDay News) -- The incidence of prostate cancer among men in Taiwan is increasing, and men with diabetes are at an increased risk of prostate cancer, according to research published in the March issue of Diabetes Care.

Abstract
Full Text (subscription or payment may be required)

Majority of Parents Approve of Smoke Exposure Testing

MONDAY, March 21 (HealthDay News) -- The majority of parents, both smokers and nonsmokers, want their children tested for tobacco-smoke exposure as part of their children's health care settings, according to a study published online March 21 in Pediatrics.

Abstract
Full Text (subscription or payment may be required)

Uterine Risk Factors Impact Endometrial Cancer Survival

FRIDAY, March 18 (HealthDay News) -- Uterine risk factors (RF) strongly influence survival of women with endometrial cancer, independent of nodal metastasis, according to research published in the March issue of the American Journal of Obstetrics & Gynecology.

Abstract
Full Text (subscription or payment may be required)

Prostatectomy Rates Higher in Hospitals With Surgical Robots

FRIDAY, March 18 (HealthDay News) -- The acquisition of surgical robots is associated with increases in the performance of radical prostatectomies (RPs) at both the hospital and regional levels, according to research published in the April issue of Medical Care.

Abstract
Full Text (subscription or payment may be required)

Inflammatory Marker Tied to Colorectal Cancer Risk

FRIDAY, March 18 (HealthDay News) -- Higher plasma levels of the soluble tumor necrosis factor receptor 2 (sTNFR-2) appear to be associated with an increased risk of colorectal cancer (CRC) among women, with anti-inflammatory drugs reducing the risk of CRC among women with high baseline sTNFR-2 levels, according to a study published in the March issue of Gastroenterology.

Abstract
Full Text (subscription or payment may be required)

Professional Values of U.S. and U.K. Doctors Examined

THURSDAY, March 17 (HealthDay News) -- A core of professional values exists among doctors in the United States and the United Kingdom, though significant differences exist in how these values are expressed and prioritized, according to a study published online March 7 in BMJ Quality & Safety.

Abstract
Full Text (subscription or payment may be required)

Novel Virus May Be Cause of Severe Febrile Illness in China

THURSDAY, March 17 (HealthDay News) -- Chinese researchers have identified a novel bunyavirus that may be the cause of severe fever with thrombocytopenia syndrome (SFTS); their research has been published online March 16 in the New England Journal of Medicine.

Abstract
Full Text (subscription or payment may be required)

High-Dose Cytarabine Not Superior to Intermediate Dose

THURSDAY, March 17 (HealthDay News) -- A high-dose regimen of cytarabine as induction therapy for acute myeloid leukemia (AML) offers no advantage over more conservative dosing and results in a higher incidence of toxic effects, according to research published in the March 17 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

Short Nurse Staffing Linked to Higher Patient Mortality

WEDNESDAY, March 16 (HealthDay News) -- Patient mortality appears to be higher when nurse staffing falls eight or more hours below target level and during nursing shifts when patient turnover is high, according to research published in the March 17 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

U.S. Death Rate Reaches All-Time Low

WEDNESDAY, March 16 (HealthDay News) -- The age-adjusted death rate for the United States has fallen for 10 straight years and has reached an all-time low of 741 per 100,000, or 2,436,682 deaths, in 2009, down 2.3 percent from 2008, according to a new report issued by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.

More Information

Heavy Smoking Prevalence Decline Greatest in California

TUESDAY, March 15 (HealthDay News) -- Between 1965 and 2007, the prevalence of high-intensity smoking declined in California and in the remaining states, according to a study published in the March 16 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Regional Variation in Chronic Disease Case Fatality Rates

TUESDAY, March 15 (HealthDay News) -- There is an inverse relationship between the regional frequency of diagnoses for chronic conditions and the case-fatality rate among fee-for-service Medicare beneficiaries, according to a study published in the March 16 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Preventive Services Underused by Older Adults in U.S.

TUESDAY, March 15 (HealthDay News) -- The aging population is growing steadily, but many older adults do not receive the preventive services they need, according to a new report issued by the U.S. Department of Health and Human Services.

Full Text

Drinking Liquor Linked to Pancreatic Cancer Mortality

TUESDAY, March 15 (HealthDay News) -- Alcohol consumption of three or more drinks per day, specifically liquor, is associated with increased pancreatic cancer mortality independent of smoking, according to a study published in the March 14 issue of the Archives of Internal Medicine.

Abstract
Full Text (subscription or payment may be required)

Local Immune Response Predictive of Cancer Prognosis

MONDAY, March 14 (HealthDay News) -- Immunological CD8 and FOXP3 cell infiltrate after neoadjuvant chemotherapy may be a predictive factor of survival for patients with breast cancer, according to a study published online Feb. 3 in The Journal of Pathology.

Abstract
Full Text (subscription or payment may be required)

Use of Virtual Colonoscopy Increasing

MONDAY, March 14 (HealthDay News) -- Even though Medicare does not cover computed tomographic-colonography (CTC), its use in hospitals is increasing, according to a study published in the March issue of the Journal of the American College of Radiology.

Abstract
Full Text

VAP-1 Predicts Mortality in Patients With Type 2 Diabetes

MONDAY, March 14 (HealthDay News) -- The level of serum vascular adhesion protein-1 (VAP-1), a protein involved in inflammation, can predict the 10-year mortality risk among patients with type 2 diabetes, according to a study published in the March issue of Diabetes.

Abstract
Full Text (subscription or payment may be required)

Tamoxifen Offers Cost-Effective Breast Cancer Prophylaxis

MONDAY, March 14 (HealthDay News) -- Tamoxifen chemoprophylaxis is a cost-effective therapy that successfully reduces breast cancer incidence among women younger than 55 years, even after the drug is discontinued, according to a study published online March 14 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Colonic Stenting No Better Than Emergency Surgery

MONDAY, March 14 (HealthDay News) -- Colonic stenting does not offer a decisive advantage over emergency surgery in patients with acute obstructive left-sided colorectal cancer, and may pose safety concerns, according to a study published online March 12 in The Lancet Oncology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

U.S. Has Higher Rates of Chronic Disease Than England

MONDAY, March 14 (HealthDay News) -- Americans experience higher rates of chronic disease and markers of disease than their English counterparts at all ages, according to a study published online March 9 in the American Journal of Epidemiology.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Lower Survival Associated With GI Brain Metastasis

FRIDAY, March 11 (HealthDay News) -- Surgical resection and whole brain radiation therapy of gastrointestinal (GI) brain metastases is associated with prolonged survival and improved quality of life, but survival is still lower compared to metastases arising from other tumors, according to a review published online Feb. 11 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Risk of Infection, Malignancy With Anti-TNF Therapy Unclear

FRIDAY, March 11 (HealthDay News) -- Patients with early rheumatoid arthritis taking anti-tumor necrosis factor (TNF) therapy without prior use of disease-modifying anti-rheumatic drugs (DMARD)/methotrexate do not have an increased risk of serious infections or malignancies, according to a meta-analysis published online Feb. 25 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Number of Cancer Survivors in U.S. Reaches 11.7 Million

THURSDAY, March 10 (HealthDay News) -- The number of cancer survivors in the United States had increased to nearly 12 million by 2007, according to a report in the March 11 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Full Text

MicroRNA Expression Tied to Prostate Cancer Recurrence

THURSDAY, March 10 (HealthDay News) -- Biochemical recurrence of localized prostate cancer in patients treated with radical prostatectomy is linked to high levels of microRNAs (miRNAs), according to a study published in the March issue of The Journal of Urology.

Abstract
Full Text

Coding of Ovarian Cancer Diagnosis Delayed

THURSDAY, March 10 (HealthDay News) -- Free text contains extra information relating to the diagnosis of ovarian cancer, and in some cases indicates a time lag between the diagnosis and coding in the medical record, according to a study published online Feb. 23 in BMJ Open.

Abstract
Full Text

HealthGrades Finds Rates of Patient Safety Events Vary

WEDNESDAY, March 9 (HealthDay News) -- Patients treated at hospitals rated with a HealthGrades Patient Safety Excellence Award have, on average, a 46 percent lower risk of experiencing a patient safety incident compared to those treated at the lowest-ranked hospitals, according to the eighth annual HealthGrades Patient Safety in American Hospitals Study published online March 9.

Full Text

Ethnic Differences Seen in Academic Measures for U.K. Docs

WEDNESDAY, March 9 (HealthDay News) -- United Kingdom-trained physicians and medical students with ethnic minority backgrounds tend to underperform academically compared to their white peers, according to a meta-analysis published online March 8 in BMJ.

Abstract
Full Text
Editorial

Blacks, Hispanics Face Breast Cancer Treatment Delays

WEDNESDAY, March 9 (HealthDay News) -- Black and Hispanic women newly diagnosed with breast cancer are more likely than white women to experience treatment delays of over a month, according to a study published in the February issue of the Journal of Health Care for the Poor and Underserved.

Abstract
Full Text (subscription or payment may be required)

Cyclophosphamide Treatment Tied to Urinary Tract Cancer

WEDNESDAY, March 9 (HealthDay News) -- Patients with systemic necrotizing vasculitides (SNV) treated with cyclophosphamide (CYC) have a five-fold higher risk of developing urinary tract cancer (UTC), according to a study published online Feb. 17 in Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

High HDL Cholesterol Tied to Decreased Colon Cancer Risk

WEDNESDAY, March 9 (HealthDay News) -- Higher concentrations of serum high-density lipoprotein (HDL) cholesterol are associated with a reduced risk of colon cancer, according to a study published online March 7 in Gut.

Abstract
Full Text (subscription or payment may be required)

Pharmacological Meta-Analyses Rarely Report Disclosures

TUESDAY, March 8 (HealthDay News) -- Meta-analyses of pharmacological treatments rarely include information addressing primary study funding and conflicts of interest (COIs) of the authors for the included randomized control trials (RCTs), according to a study published in the March 9 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Cancer Risk Up in Taiwanese With Rheumatoid Arthritis

MONDAY, March 7 (HealthDay News) -- Taiwanese patients diagnosed with rheumatoid arthritis (RA) have an increased cancer risk, particularly for hematological, kidney, and vagina/vulva cancers, according to a study published in the February issue of Arthritis & Rheumatism.

Abstract
Full Text (subscription or payment may be required)

Zalutumumab Beneficial in Head-and-Neck Cancer

MONDAY, March 7 (HealthDay News) -- Zalutumumab, a human IgG1 monoclonal antibody targeting the epidermal growth factor receptor, appears to significantly prolong progression-free survival (PFS) in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck after failure of platinum-based chemotherapy, according to a study published online March 7 in The Lancet Oncology.

Abstract
Full Text (subscription or payment may be required)

Cancer Patients Willing to Undergo Pre-Trial Testing

MONDAY, March 7 (HealthDay News) -- Patients with advanced malignancies appear to be quite willing to undergo pharmacodynamic (PD) and pharmacokinetic (PK) tests in order to be enrolled in clinical trials, according to research published online Jan. 18 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Risk Factors Identified for Catheter-Related Thrombosis

MONDAY, March 7 (HealthDay News) -- The risk of catheter-related thrombosis (CRT) is decreased by use of implanted ports and increased by previous history of deep vein thrombosis, insertion into the subclavian vein, and improper catheter tip position, according to a review published in the February issue of the Journal of Thrombosis and Haemostasis.

Abstract
Full Text (subscription or payment may be required)

Smoking Hurts Head-and-Neck Cancer Outcomes

FRIDAY, March 4 (HealthDay News) -- Cigarette smoking during radiation therapy for head-and-neck cancer is associated with a worse clinical outcome, according to a study published in the February issue of the International Journal of Radiation Oncology*Biology*Physics.

Abstract
Full Text (subscription or payment may be required)

Progressive Spinal Metastases Respond to Reirradiation

FRIDAY, March 4 (HealthDay News) -- Stereotactic body radiotherapy results in good radiographic control and limited toxicity in progressive spinal metastases, according to a study published online Feb. 11 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Inflammatory Bowel Disease Tied to Thromboembolism Risk

FRIDAY, March 4 (HealthDay News) -- Patients suffering from inflammatory bowel disease (IBD) have twice the risk of developing venous thromboembolism (VTE) compared to the general population, according to a study published online Feb. 21 in Gut.

Abstract
Full Text (subscription or payment may be required)

Molecular Tumor Burden Predicts Colon Cancer Outcome

THURSDAY, March 3 (HealthDay News) -- In patients with node-negative colorectal cancer, the occult molecular tumor burden in the lymph nodes is an independent predictor of the time to recurrence and disease-free survival, according to a study published online Feb. 9 in Clinical Cancer Research.

Abstract
Full Text (subscription or payment may be required)

Eribulin Improves Survival in Metastatic Breast Cancer

THURSDAY, March 3 (HealthDay News) -- Among women with heavily pretreated metastatic breast cancer, eribulin mesilate may significantly improve survival compared to currently available treatments, according to a study published online March 3 in The Lancet.

Abstract
Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Role of Diabetes in Premature Death Is Substantial

WEDNESDAY, March 2 (HealthDay News) -- Diabetes is substantially associated with premature mortality from cancers, infectious diseases, external causes, intentional self-harm, and degenerative disorders, according to research published in the March 3 issue of the New England Journal of Medicine.

Full Text (subscription or payment may be required)

FDA: Proton Pump Inhibitors Tied to Hypomagnesemia

WEDNESDAY, March 2 (HealthDay News) -- The U.S. Food and Drug Administration has notified health care providers and consumers that taking prescription proton pump inhibitor (PPI) drugs for prolonged periods of time, particularly for longer than one year, may be associated with low serum magnesium levels (hypomagnesemia).

More Information

Current and Former Smokers at Higher Breast Cancer Risk

WEDNESDAY, March 2 (HealthDay News) -- Postmenopausal women who used to smoke or who currently smoke appear to be at a higher risk of invasive breast cancer than postmenopausal women who never smoked, according to a study published online March 1 in BMJ.

Abstract
Full Text
Editorial (subscription or payment may be required)

Fish Oil May Help Cancer Patients Maintain Weight

WEDNESDAY, March 2 (HealthDay News) -- Supplementation with fish oil (FO) may help non-small-cell lung cancer patients maintain weight and muscle mass during chemotherapy, according to research published online Feb. 28 in Cancer.

Abstract
Full Text (subscription or payment may be required)

Obesity Associated With Risk of Dissimilar Breast Cancers

WEDNESDAY, March 2 (HealthDay News) -- High body mass index (BMI) and low levels of physical activity are associated with increased risk of triple-negative and estrogen receptor-positive (ER+) breast cancers in postmenopausal women, according to a study published online March 1 in Cancer Epidemiology, Biomarkers & Prevention.

Abstract
Full Text (subscription or payment may be required)

Inhaled Nitric Oxide Does Not Shorten Sickle Cell Crisis

WEDNESDAY, March 2 (HealthDay News) -- Among patients with sickle cell disease (SCD), the use of inhaled nitric oxide does not reduce the time to resolution of a vaso-occlusive pain crisis (VOC) compared to placebo, according to a study published in the March 2 issue of the Journal of the American Medical Association.

Abstract
Full Text (subscription or payment may be required)

Type of Health Care-Associated Infections Is Falling

TUESDAY, March 1 (HealthDay News) -- The incidence of central line-associated blood stream infections (CLABSIs) in intensive care units (ICUs) has decreased by more than half since 2001, but the infections continue to occur in substantial numbers in inpatient wards and outpatient hemodialysis centers, according to research published in the March 1 early-release issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

Full Text

U.S. Breast Cancer Incidence Rates Stabilized After 2003

TUESDAY, March 1 (HealthDay News) -- Breast cancer incidence rates among non-Hispanic (NH) white women in the United States stabilized between 2003 and 2007 after a sharp decline between 2002 and 2003 that followed a drop in the use of postmenopausal hormone therapy, according to a study published online Feb. 28 in Cancer Epidemiology, Biomarkers & Prevention.

Abstract
Full Text (subscription or payment may be required)

New Laser-Based Tool Accurately Identifies Melanoma

TUESDAY, March 1 (HealthDay News) -- A new laser-based tool may help physicians better diagnose melanoma, according to research published in the Feb. 23 issue of Science Translational Medicine.

Abstract
Full Text (subscription or payment may be required)

Opioid Treatment Associated With Cognitive Dysfunction

TUESDAY, March 1 (HealthDay News) -- One-third of opioid-treated patients with cancer have possible or definite cognitive dysfunction, according to a study published online Feb. 28 in the Journal of Clinical Oncology.

Abstract
Full Text (subscription or payment may be required)

Specialties Hematology & Oncology

Copyright © 2011 ScoutNews, LLC. All rights reserved.


I Wish You Knew

HPV is now one of the main risk factors for head & neck cancers

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More